After receiving the Moderna Covid-19 vaccine on January 10, over 1,200 adverse events were reported, with 10 cases classified as anaphylaxis. This comes from a report released Friday by the U.S. Centers for Disease Control and Prevention (CDC).
The U.S. Food and Drug Administration issued an emergency approval on December 18, 2020 for the Moderna Covid-19 vaccine, which is given in two doses one month apart to prevent Covid-19, Xinhua news agency reported.
As of January 10, 40,41,396 first doses of the Moderna Covid-19 vaccine had been administered in the United States and reports of 1,266 post-receipt of the Moderna Covid-19 vaccine had been submitted to the Vaccine Adverse Event Reporting System to the CDC.
Among these, 108 case reports were identified for further review as possible cases of severe allergic reactions, including anaphylaxis.
Anaphylaxis is a life-threatening allergic reaction that rarely occurs after vaccination and typically starts within minutes to hours.
Among those case reports, 10 cases were classified as anaphylaxis, a rate of 2.5 anaphylaxis cases per million Moderna Covid-19 vaccine doses administered, according to the CDC.
The mean time from receiving the vaccine to showing symptoms was 7.5 minutes.
The CDC urged sites that deliver Covid-19 vaccines to adhere to CDC guidelines, including screening recipients for contraindications and precautions, providing the necessary supplies and staff to treat the anaphylaxis, implementing the recommended Observation periods after vaccination and immediate treatment of suspected anaphylaxis with intramuscular adrenaline injection.
int / rs /
(Only the headline and image of this report may have been revised by Business Standard staff. The rest of the content is automatically generated from a syndicated feed.)
Business Standard has always endeavored to provide updated information and commentary on developments that are of interest to you and have far-reaching political and economic implications for the country and the world. Your encouragement and constant feedback to improve our offering has only strengthened our resolve and commitment to these ideals. Even in these troubled times resulting from Covid-19, we continue to strive to keep you updated with credible news, authoritative views, and concise comments on relevant topics.
However, we have a request.
As we struggle against the economic impact of the pandemic, we need your support even more so that we can continue to offer you higher quality content. Our subscription model has received an encouraging response from many of you who have subscribed to our online content. A larger subscription to our online content can only help us achieve our goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practice the journalism to which we are committed.
Support of quality journalism and Subscribe to Business Standard.